NovoCure Limited
NVCR
$11.19
-$0.49-4.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.29% | 2.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.29% | 2.46% | |||
| Cost of Revenue | 7.85% | 7.66% | |||
| Gross Profit | 4.38% | 0.74% | |||
| SG&A Expenses | 3.41% | 0.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.47% | 2.83% | |||
| Operating Income | 8.86% | -4.37% | |||
| Income Before Tax | 14.17% | -15.46% | |||
| Income Tax Expenses | 40.47% | 28.23% | |||
| Earnings from Continuing Operations | 7.15% | -16.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.15% | -16.96% | |||
| EBIT | 8.86% | -4.37% | |||
| EBITDA | 10.31% | -4.45% | |||
| EPS Basic | 7.45% | -15.62% | |||
| Normalized Basic EPS | 14.40% | -14.09% | |||
| EPS Diluted | 7.45% | -15.62% | |||
| Normalized Diluted EPS | 14.40% | -14.09% | |||
| Average Basic Shares Outstanding | 0.30% | 1.17% | |||
| Average Diluted Shares Outstanding | 0.30% | 1.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||